Combination treatment with the cap-dependent endonuclease inhibitor baloxavir marboxil and a neuraminidase inhibitor in a mouse model of influenza A virus infection
Author:
Affiliation:
1. Drug Discovery & Disease Research Laboratory, Shionogi & Co., Ltd., Osaka, Japan
2. Shionogi TechnoAdvance Research, Co., Ltd., Osaka, Japan
Funder
Shionogi and Co., Ltd
Publisher
Oxford University Press (OUP)
Subject
Infectious Diseases,Pharmacology (medical),Pharmacology,Microbiology (medical)
Link
http://academic.oup.com/jac/article-pdf/74/3/654/27785362/dky462.pdf
Reference39 articles.
1. Enhancement of the influenza A hemagglutinin (HA)-mediated cell-cell fusion and virus entry by the viral neuraminidase (NA);Su;PLoS One,2009
2. Neuraminidase inhibitors for influenza;Moscona;N Engl J Med,2005
3. Surveillance for neuraminidase inhibitor resistance among human influenza A and B viruses circulating worldwide from 2004 to 2008;Sheu;Antimicrob Agents Chemother,2008
4. Effectiveness of neuraminidase inhibitors in reducing mortality in patients admitted to hospital with influenza A H1N1pdm09 virus infection: a meta-analysis of individual participant data;Muthuri;Lancet Respir Med,2014
5. Zanamivir for influenza in adults and children: systematic review of clinical study reports and summary of regulatory comments;Heneghan;BMJ,2014
Cited by 69 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Identification of potential antiviral compounds from Egyptian sea stars against seasonal influenza A/H1N1 virus;Journal of Genetic Engineering and Biotechnology;2024-03
2. Prophylactic Treatment with Baloxavir Protects Mice from Lethal Infection with Influenza A and B Viruses;Viruses;2023-11-16
3. Baloxavir marboxil use for critical human infection of avian influenza A H5N6 virus;2023-09-05
4. Development and validation of an ultra‐performance liquid chromatography–tandem mass spectrometry method for the determination of baloxavir in rat plasma and its application to pharmacokinetic studies;Biomedical Chromatography;2023-08-31
5. Efficacy of favipiravir against influenza virus resistant to both baloxavir and neuraminidase inhibitors;Journal of Antimicrobial Chemotherapy;2023-05-20
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3